Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Blood|March 13, 2010
Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selectionStephen A Beers, Ruth R French, H T Claude Chan, et al.
Current Medicinal Chemistry|April 16, 2004
Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cellsSara M E Osford, Claire L Dallman, Peter W M Johnson, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2019
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volumeLuca Ceriani, Lisa Milan, Peter W M Johnson, et al.
Haematologica|September 13, 2005
The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cellsSilvia Coenen, Becky Pickering, Kathleen N Potter, et al.
British Journal of Haematology|February 21, 2006
Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphomaJorg Michels, Vipul Foria, Ben Mead, et al.
Current Biology : CB|July 18, 2003
Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcriptionAlexander H Mirnezami, Sandra J Campbell, Matthew Darley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519)Peter W M Johnson, Matthew R Sydes, Barry W Hancock, et al.
Pageof 11